Personal profile
Research Interests
Natural Product Screening
External positions
Fingerprint
Dive into the research topics where Richard Lobo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Diosgenin-mediated NF-κB and MAPK pathway modulation for osteoarthritis treatment: molecular mechanisms, bioavailability enhancement, and therapeutic applications
Adarkar, R., Viswambharan, V. L., Dessai, A., Lobo, R., Tippavajhala, V. K., Pai, V., Subraya, C. K. & Aswatha Ram, H. N., 2026, (Accepted/In press) In: Inflammopharmacology. 34, 2, p. 833-851 19 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Pharmacological Complexities of Herbal Medicinal Extracts: A Review of Bioavailability, Interactions, and Standardization
Ramesh, M. M., Dinesh, S., Venkatappa, A. H. & Lobo, R., 2026, (Accepted/In press) In: Current Drug Metabolism.Research output: Contribution to journal › Review article › peer-review
-
Sesbania grandiflora (L.) Pers. A review of its phytochemistry, molecular pharmacology, and clinical potential
Viswambharan, V. L., Ramesh, M. M., Adarkar, R., Nison, M., Kotian, M., Pai, V. R., Bhat, C. K. S. & Lobo, R., 03-2026, In: Journal of Applied Pharmaceutical Science. 16, 3, p. 1-13 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Comprehensive Review on the Pharmacological Potential of Dioscorea bulbifera and its Potential Hepatotoxicity
Adarkar, R., Chandrashekar, K. S., Pai, V., Lobo, R., Aswatharam, H. N., Tippavajhala, V. K., D’Souza, U. P. & Shankara, R. K., 01-2025, In: Pharmacognosy Journal. 17, 4, p. 520-530 11 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Computational design, synthesis, in vitro and in vivo evaluation of a 3,4-methylenedioxyphenol (sesamol) derivative as an NRF2/HO-1 pathway activator for protection against drug-induced liver injury
Mili, A., Birangal, S., Nandakumar, K., Hariharapura, R. C., Kumar, N., Pai, A. & Lobo, R., 2025, In: RSC Advances. 15, 56, p. 48092-48108 17 p.Research output: Contribution to journal › Article › peer-review
Open Access